TW200503706A - Treating and/or preventing agent for pulmonary diseases - Google Patents

Treating and/or preventing agent for pulmonary diseases

Info

Publication number
TW200503706A
TW200503706A TW093108847A TW93108847A TW200503706A TW 200503706 A TW200503706 A TW 200503706A TW 093108847 A TW093108847 A TW 093108847A TW 93108847 A TW93108847 A TW 93108847A TW 200503706 A TW200503706 A TW 200503706A
Authority
TW
Taiwan
Prior art keywords
induced asthma
treating
acidophilic
preventing agent
pulmonary diseases
Prior art date
Application number
TW093108847A
Other languages
English (en)
Inventor
Motoya Mie
Kaori Akuta
Haruhiko Manabe
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of TW200503706A publication Critical patent/TW200503706A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW093108847A 2003-03-31 2004-03-31 Treating and/or preventing agent for pulmonary diseases TW200503706A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003094503 2003-03-31

Publications (1)

Publication Number Publication Date
TW200503706A true TW200503706A (en) 2005-02-01

Family

ID=33127391

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093108847A TW200503706A (en) 2003-03-31 2004-03-31 Treating and/or preventing agent for pulmonary diseases

Country Status (3)

Country Link
JP (1) JPWO2004087147A1 (zh)
TW (1) TW200503706A (zh)
WO (1) WO2004087147A1 (zh)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030645A (en) * 1990-10-15 1991-07-09 Merck & Co., Inc. Method of treating asthma using (S)-α-fluoromethyl-histidine and esters thereof
PT771794E (pt) * 1995-05-19 2006-09-29 Kyowa Hakko Kogyo Kk Compostos heterociclicos contendo oxigenio
WO1999037640A1 (fr) * 1998-01-26 1999-07-29 Kyowa Hakko Kogyo Co., Ltd. Composes heterocycliques oxygenes
AU764005B2 (en) * 1999-02-25 2003-08-07 Merck Frosst Canada & Co. PDE IV inhibiting compounds, compositions and methods of treatment
AR035987A1 (es) * 1999-03-01 2004-08-04 Smithkline Beecham Corp Uso de un compuesto inhibidor de la pde 4 para la manufactura de un medicamento y el medicamento para tratar asma inducida por ejercicio
GB0113342D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 1
TWI221838B (en) * 2001-08-09 2004-10-11 Tanabe Seiyaku Co Pyrazinoisoquinoline compound or naphthalene compound
DE10205274A1 (de) * 2002-02-08 2003-08-21 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen
EP1535920A4 (en) * 2002-07-03 2007-03-21 Kyowa Hakko Kogyo Kk PROCESS FOR THE PREPARATION OF 1,3-BENZODIOXOLE-2-SPIRO-CYCLOALCAN DERIVATIVES

Also Published As

Publication number Publication date
WO2004087147A1 (ja) 2004-10-14
JPWO2004087147A1 (ja) 2006-06-29

Similar Documents

Publication Publication Date Title
EP1518855A4 (en) DIAMINOPYRIMIDINECARBOXAMIDE DERIVATIVE
JO2311B1 (en) Alkyl inhibitors Ariel phosphodiesterase-4
RS52731B (sr) Farmaceutska kompozicija za upotrebu u lečenju ateroskleroze, dislipidemija i sa njima povezanih stanja
WO2004021989A3 (en) Imidazolopyridines and methods of making and using the same
WO2009005877A3 (en) Alpha-i antitrypsin having no significant serine protease inhibitor activity
TR200201880T2 (tr) PDE4 izozimerlerinin seçici önleyicileri olarak faydalı nikotinamit benzobağlı-heterosiklil türevleri
BR0112292A (pt) Composto, composição farmacêutica, método para tratar ou prevenir disfunções tromboembólicas e uso de um composto
MY142441A (en) Azole derivatives as inhibitors of lipases and phospholipases
CA2415966A1 (en) Tetrahydro-heterocycloazepinyl pyrimidine derivatives
WO2002010135A1 (fr) Composes derives de 3,4-dihydroisoquinoline et medicaments contenant ces composes comme principe actif
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
EP0795548A4 (en) CHINAZOZINE DERIVATIVES AND THEIR USE
NO20063572L (no) Kinazolinditosylatsalt forbindelser
WO2000071493A3 (en) INHIBITORS OF FACTOR Xa
PL369897A1 (en) Inner part for a refrigerating device
HK1042656A1 (zh) 間質性肺炎和肺纖維化癥的預防和治療藥物
WO2001045679A3 (de) Verwendung von chemotherapeutika zur topischen behandlung
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
RS54185B1 (en) USE OF 24-ORDER
NO984330D0 (no) Benzopyranderivater som har leukotrien-antagonistisk virkning
GEP20084437B (en) Novel lincomycin derivatives possessing antimicrobial activity
AU2003238475A1 (en) 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses
WO2008015139A3 (en) Inhibitors of zinc proteases thioaryl substituted and their use
WO2008045663A3 (en) Aryl-substituted heterocyclic pde4 inhibitors as antiinflammatory agents
CA2427814A1 (en) A combination of a pde4 inhibitor and a leukotriene antagonist in the treatment of bronchial and respiratory disorders